Study Status Reporting

SponsorsThis information is required in order for the Board to conduct continuing review of the protocol.

Six to eight weeks prior to the expiration date of a study’s approval period, the sponsor or CRO must submit a completed Protocol Continuing Review Form and any supporting documentation to Schulman as described on the form.

If you are submitting a site-related Study Status Report on behalf of the site, please reference Study Status Reporting for Sites.